CA 242 is a new tumor marker for pancreatic cancer
نویسندگان
چکیده
منابع مشابه
CA 19-9 tumor marker: is it reliable? A case report in a patient with pancreatic cancer.
Pancreatic cancer is one of the most lethal malignancies affecting mankind. At the time of diagnosis, only 20% of patients are considered eligible for surgery and approximately one half of these patients undergo successful resection. For patients with locally advanced or metastatic disease, the median survival time is less than 1 year.1-4 Thus, it is crucial to diagnose or detect the recurrence...
متن کاملALDH as a tumor marker for pancreatic cancer.
We had the pleasure of reading the article “Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) as candidates for tumor markers in patients with pancreatic cancer” published by Jelski et al in the last issue of the Journal of Gastrointestinal and Liver Diseases, in which the Polish research group describe the potential role of ALDH as a tumor marker for pancreatic carcinoma, along wit...
متن کاملCirculating Tumor Cells as a Prognostic Marker in Pancreatic Cancer
Pancreatic cancer, with a patient survival rate among the worst of any solid cancer, is the fourth leading cause of cancer-related morbidity and mortality in Western countries (Tjensvoll et al., 2013). It leads to an estimated 227, 000 deaths per year worldwide and the 5 year survival rate is only 4.6% due to its early metastasis (Zhou et al., 2011). Most of the pancreatic cancer patients are a...
متن کاملIs Bax/Bcl-2 Ratio Considered as a Prognostic Marker with Age and Tumor Location in Colorectal Cancer?
Background: Bax and Bcl-2 are the major members of Bcl-2 family whose play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction. Therefore, the balance between pro- and anti-apoptotic members of this family can determine the cellular fate. Methods: In this study, the relative level of mRNA expression of Bax and Bcl-2 genes was deter...
متن کاملTumor marker CA 15-3 in breast cancer patients.
OBJECTIVE The aim of this study was to determine whether there is a correlation between the serum concentration of the tumor marker CA 15-3 and breast cancer, which has not been proven by the existence of regional and distant metastases, and breast cancer with the presence of regional and distant metastases. PATIENTS AND METHODS The study was a retrospective-prospective study, and was conduct...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1993
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(19930201)71:3<701::aid-cncr2820710308>3.0.co;2-c